Skip to content

Author

H. M. Selim

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Niflumic Acid-Loaded Aspasomes as a Repurposed Nanoplatform: Antitumor Effects and Modulation of PI3K/AKT/mTOR Pathway-Related Molecular Markers in Solid Ehrlich Carcinoma-Bearing Mice

Background/Objectives: Breast cancer remains a major global health challenge, with the PI3K/AKT/mTOR signaling axis playing a key role in tumor progression. Drug repurposing offers an efficient approach to cancer therapeutics. Niflumic acid (NIF), a selective cyclooxygenase-2 (COX-2) inhibitor, has demonstrated antipro...

M. M. Mostafa, S. M. Abd El-Halim, Mira Magdy William et al. · 0 citations
Review Oct 2026

Gut Microbiota-Derived Extracellular Vesicles in Cancer: Friends or Foes?

A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, and Google Scholar without time restrictions using standardized keywords related to gut microbiota, extracellular vesicles, and cancer.

H. M. Selim, Dalaal M. Abdallah, Amira A. El-Gazar et al. · 0 citations
Oct 2026

Elucidating the Therapeutic Mechanisms of Nickel(II)– Hydroazinecarbothioamide Complexes Across Cancer, Microbial, and Oxidative Stress Models

Isatin‐based ligands have been recognized for their remarkable pharmacological potential and this study reports the synthesis, characterization, and biological evaluation of three novel nickel(II)‐isatin hydrazone complexes ( C1–C3 ). The complexes were characterized by FT‐IR, UV–vis, mass spectroscopy, DFT, magn...

Asmaa Saleh, Hend A. A. Ezelarab, H. M. Selim et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.